Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Phibro Animal Health (PAHC) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Phibro Animal Health (PAHC) over the last 14 years, with Q4 2025 value amounting to 13.46%.

  • Phibro Animal Health's EBITDA Margin rose 52000.0% to 13.46% in Q4 2025 from the same period last year, while for Dec 2025 it was 11.53%, marking a year-over-year increase of 41500.0%. This contributed to the annual value of 8.52% for FY2025, which is 32800.0% up from last year.
  • Latest data reveals that Phibro Animal Health reported EBITDA Margin of 13.46% as of Q4 2025, which was up 52000.0% from 14.09% recorded in Q3 2025.
  • Over the past 5 years, Phibro Animal Health's EBITDA Margin peaked at 14.09% during Q3 2025, and registered a low of 0.31% during Q3 2023.
  • Over the past 5 years, Phibro Animal Health's median EBITDA Margin value was 8.13% (recorded in 2022), while the average stood at 8.11%.
  • In the last 5 years, Phibro Animal Health's EBITDA Margin tumbled by -62000bps in 2023 and then soared by 72900bps in 2025.
  • Phibro Animal Health's EBITDA Margin (Quarter) stood at 9.58% in 2021, then tumbled by -32bps to 6.48% in 2022, then dropped by -3bps to 6.28% in 2023, then skyrocketed by 31bps to 8.26% in 2024, then skyrocketed by 63bps to 13.46% in 2025.
  • Its EBITDA Margin stands at 13.46% for Q4 2025, versus 14.09% for Q3 2025 and 8.9% for Q2 2025.